However, the findings can be reconciled by taking into account the fact that the mouse models used by Dodd et al.110 and Hirbe et al.111 do not recapitulate the physiological stepwise progression from benign to malignant tumour in human NF1 patients, as is the case in Brosseau et al.107. The gene discussed is NF1; the disease is cancer.